dihydrosphingosine

dihydrosphingosine information and resources from the National Cancer Institute

dihydrosphingosine

A saturated derivative of sphingosine. As an inhibitor of protein kinase C (PKC), dihydrosphingosine competitively binds to the regulatory phorbol-binding domain of PKC, a kinase involved in tumorigenesis. This agent has been shown to act synergistically with other chemotherapeutic agents and may potentiate chemotherapy drug-induced apoptosis in vitro and in vivo.

dihydrosphingosine -->

Home | About | Search topics | Cancers | Treatment | Medications
Onconews provides free news and resources on cancer-related topics.

Copyright onconews.org 2005-2006.
All Rights Reserved.
Google
 
Web onconews.org